Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cara Haymaker

Showing results (81-90 of 108) with videos related to

Pageof 11
Sort By:
Nature Communications|February 2, 2020
Bempegaldesleukin selectively depletes intratumoral Tregs and potentiates T cell-mediated cancer therapyMeenu Sharma, Hiep Khong, Faisal Fa'ak, et al.
Cancer Immunology, Immunotherapy : CII|October 30, 2020
Aurora kinase inhibition sensitizes melanoma cells to T-cell-mediated cytotoxicitySimone Punt, Shruti Malu, Jodi A McKenzie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2026
Addition of Metastasis-Directed Therapy to Standard of Care for Oligometastatic Solid Tumors: Primary Analysis of All Tumor-Histology Baskets of the Phase II Randomized EXTEND TrialAlexander D Sherry, Cara Haymaker, Shuqi Wang, et al.
Cell|August 8, 2025
Vagal blockade of the brain-liver axis deters cancer-associated cachexiaAliesha Garrett, Naama Darzi, Ashlesha Deshmukh, et al.
Nature Communications|August 20, 2021
Nodal immune flare mimics nodal disease progression following neoadjuvant immune checkpoint inhibitors in non-small cell lung cancerTina Cascone, Annikka Weissferdt, Myrna C B Godoy, et al.
The Lancet. Oncology|August 7, 2022
Durvalumab plus tremelimumab in advanced or metastatic soft tissue and bone sarcomas: a single-centre phase 2 trialNeeta Somaiah, Anthony P Conley, Edwin Roger Parra, et al.
Nature Communications|June 29, 2026
A pilot translational study of neoadjuvant fulvestrant plus abemaciclib in women with advanced low-grade serous carcinomaLauren P Cobb, Yibo Dai, Max Molina Ayala, et al.
European Urology|August 1, 2025
Continuous Androgen Deprivation Therapy with or Without Metastasis-directed Therapy for Oligometastatic Prostate Cancer: The Multicenter Phase 2 Randomized EXTEND TrialAlexander D Sherry, Bilal A Siddiqui, Cara Haymaker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2024
Addition of Metastasis-Directed Therapy to Systemic Therapy for Oligometastatic Pancreatic Ductal Adenocarcinoma (EXTEND): A Multicenter, Randomized Phase II TrialEthan B Ludmir, Alexander D Sherry, Bryan M Fellman, et al.
JCO Clinical Cancer Informatics|August 9, 2022
Shared Nearest Neighbors Approach and Interactive Browser for Network Analysis of a Comprehensive Non-Small-Cell Lung Cancer Data SetStephanie T Schmidt, Neal Akhave, Ryan E Knightly, et al.
Pageof 11

Showing results (81-90 of 108) with videos related to

Sort By:
Pageof 11
Nature Communications|February 2, 2020
Bempegaldesleukin selectively depletes intratumoral Tregs and potentiates T cell-mediated cancer therapyMeenu Sharma, Hiep Khong, Faisal Fa'ak, et al.
Cancer Immunology, Immunotherapy : CII|October 30, 2020
Aurora kinase inhibition sensitizes melanoma cells to T-cell-mediated cytotoxicitySimone Punt, Shruti Malu, Jodi A McKenzie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2026
Addition of Metastasis-Directed Therapy to Standard of Care for Oligometastatic Solid Tumors: Primary Analysis of All Tumor-Histology Baskets of the Phase II Randomized EXTEND TrialAlexander D Sherry, Cara Haymaker, Shuqi Wang, et al.
Cell|August 8, 2025
Vagal blockade of the brain-liver axis deters cancer-associated cachexiaAliesha Garrett, Naama Darzi, Ashlesha Deshmukh, et al.
Nature Communications|August 20, 2021
Nodal immune flare mimics nodal disease progression following neoadjuvant immune checkpoint inhibitors in non-small cell lung cancerTina Cascone, Annikka Weissferdt, Myrna C B Godoy, et al.
The Lancet. Oncology|August 7, 2022
Durvalumab plus tremelimumab in advanced or metastatic soft tissue and bone sarcomas: a single-centre phase 2 trialNeeta Somaiah, Anthony P Conley, Edwin Roger Parra, et al.
Nature Communications|June 29, 2026
A pilot translational study of neoadjuvant fulvestrant plus abemaciclib in women with advanced low-grade serous carcinomaLauren P Cobb, Yibo Dai, Max Molina Ayala, et al.
European Urology|August 1, 2025
Continuous Androgen Deprivation Therapy with or Without Metastasis-directed Therapy for Oligometastatic Prostate Cancer: The Multicenter Phase 2 Randomized EXTEND TrialAlexander D Sherry, Bilal A Siddiqui, Cara Haymaker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2024
Addition of Metastasis-Directed Therapy to Systemic Therapy for Oligometastatic Pancreatic Ductal Adenocarcinoma (EXTEND): A Multicenter, Randomized Phase II TrialEthan B Ludmir, Alexander D Sherry, Bryan M Fellman, et al.
JCO Clinical Cancer Informatics|August 9, 2022
Shared Nearest Neighbors Approach and Interactive Browser for Network Analysis of a Comprehensive Non-Small-Cell Lung Cancer Data SetStephanie T Schmidt, Neal Akhave, Ryan E Knightly, et al.
Pageof 11